))
Niklas Kouparanis, Co-Founder & CEO of Bloomwell Group
Arkiveret serie ("Inaktivt feed" status)
When?
This feed was archived on May 05, 2024 13:07 (
Why? Inaktivt feed status. Vores servere kunne ikke hente et gyldigt podcast-feed i en længere periode.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 329857687 series 3329935
Indhold leveret af Professionally Cannabis and Psychedelics and Professionally Cannabis. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Professionally Cannabis and Psychedelics and Professionally Cannabis eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
For this week’s episode, we talk cannabis in Germany with Niklas Kouparanis, the Co-Founder & CEO of Bloomwell Group.
With the biggest medical cannabis market in Europe and imminent plans to pass new laws permitting recreational use of the plant, Nik joins us to discuss the practicalities, time lines and critical success factors for Germany, as adult-use cannabis in the country has moved from an ‘if’ to a ‘when’.
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/
87 episoder
Del
